Gadobutrol Deemed Safe in Early Analysis
CHICAGO (MedPage Today) — A new MRI contrast agent, gadobutrol, was well-tolerated and safe according to results in more than 15,000 patients, researchers said here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com